The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Sourcing · Regulatory · continued

Reading a regulatory notice rather than an article about it — what changed since posts 31–33

This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.

P
preregisteredTL330 Jun 2025#31
YR
y.rahimiTL22 Jul 2025#32

Date every claim in this subcategory. A regulatory position stated without a date is worse than no claim, because it will be read as current indefinitely.

4 likes 13mo
AD
appeals_deskTL3Regular3 Jul 2025 · edited#33

Adding the measurement that post #30 says would settle it.

Regulatory approval is a decision about a specific product from a specific manufacturer. It does not travel to a different product containing the same molecule.

If this contradicts something upthread, the upthread version may well be the better one.

17 likes 13mo

Suggested topics

TopicParticipantsRepliesViewsActivity
Why a compound being unapproved is not the same as being illegal to possess
Why a compound being unapproved is not the same as being illegal to possess I have a specific reason for asking rather than idle curiosity, and the context is below. Collecting what is known about compound…
LCFNJBSCAN+72 78 23k 3mo
Import rules for personal quantities, by jurisdiction, dated
On the subject in the title: Import rules for personal quantities, by jurisdiction, dated Working notes rather than a conclusion. I was wrong about import rules for personal quantities in a thread last spring…
MDFNBRAN 3 60k 12mo
Pharmaceutical compounding rules, summarised from primary sources
Pharmaceutical compounding rules, summarised from primary sources — setting out what I have, and where I think it stops being reliable. Asking what a regulator's document actually says, since the summaries of…
BJMBEDRIIL+135 163 46k 17mo
What a regulator's shortage notice actually authorises
What a regulator's shortage notice actually authorises — that is the question, and I have not found it answered plainly anywhere I have looked. Asking what a regulator's document actually says, since the…
BESCAAQLSG+8 12 15k 17h
Enforcement priorities versus written rules
Enforcement priorities versus written rules — setting out what I have, and where I think it stops being reliable. Asking what a regulator's document actually says, since the summaries of it disagree. I have…
NSMINV 2 62k 15mo

Related topics — sharing the tags research use only, MHRA, FDA

TopicParticipantsRepliesViewsActivity
Second pass at: Reimbursement variation across member states
On the subject in the title: Second pass at: Reimbursement variation across member states Working notes rather than a conclusion. The question about Reimbursement variation across member states that I…
APCDACBRSB+23 28 45k 21mo
Canadian access and provincial variation
Posting this under the heading it deserves: Canadian access and provincial variation Everything below is what sits behind that. Trying to establish the boundary conditions on canadian access and provincial…
POCLNNTPFV+74 80 7.7k 18mo
Coverage in the US: a map of the usual obstacles
Coverage in the US: a map of the usual obstacles — setting out what I have, and where I think it stops being reliable. Trying to establish the boundary conditions on coverage. The general claim is fine; I…
GPMYASKHFA+46 50 7.9k 5mo
Personal import allowances, compared — a second dataset
Personal import allowances, compared — a second dataset — setting out what I have, and where I think it stops being reliable. Posting a small dataset on Personal import allowances. It is mine, it is…
CCJHKSAVN+124 132 9.2k 2mo
Pharmaceutical compounding rules, summarised from primary sources
Pharmaceutical compounding rules, summarised from primary sources — setting out what I have, and where I think it stops being reliable. Asking what a regulator's document actually says, since the summaries of…
BJMBEDRIIL+135 163 46k 17mo